CV vs. LLY
Compare and contrast key facts about CapsoVision, Inc (CV) and Eli Lilly and Company (LLY).
Performance
CV vs. LLY - Performance Comparison
Loading graphics...
CV vs. LLY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
CV CapsoVision, Inc | -31.81% | 205.43% |
LLY Eli Lilly and Company | -14.27% | 38.41% |
Fundamentals
CV:
$1.79B
LLY:
$825.96B
CV:
-$0.22
LLY:
$22.96
CV:
60.62
LLY:
12.68
CV:
135.00
LLY:
31.13
CV:
$13.55M
LLY:
$65.18B
CV:
$7.17M
LLY:
$54.62B
CV:
-$29.86M
LLY:
$27.94B
Returns By Period
In the year-to-date period, CV achieves a -31.81% return, which is significantly lower than LLY's -14.27% return.
CV
- 1D
- 1.82%
- 1M
- 32.79%
- YTD
- -31.81%
- 6M
- 50.62%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
LLY
- 1D
- 3.74%
- 1M
- -12.57%
- YTD
- -14.27%
- 6M
- 20.93%
- 1Y
- 12.19%
- 3Y*
- 39.90%
- 5Y*
- 39.16%
- 10Y*
- 30.92%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CV vs. LLY — Risk / Return Rank
CV
LLY
CV vs. LLY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for CapsoVision, Inc (CV) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Loading graphics...
Sharpe Ratios by Period
| CV | LLY | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | — | 0.29 | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 1.23 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 1.04 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 1.57 | 0.56 | +1.01 |
Correlation
The correlation between CV and LLY is 0.11, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
CV vs. LLY - Dividend Comparison
CV has not paid dividends to shareholders, while LLY's dividend yield for the trailing twelve months is around 0.68%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CV CapsoVision, Inc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
LLY Eli Lilly and Company | 0.68% | 0.56% | 0.67% | 0.78% | 1.07% | 1.23% | 1.75% | 1.96% | 1.94% | 2.46% | 2.77% | 2.37% |
Drawdowns
CV vs. LLY - Drawdown Comparison
The maximum CV drawdown since its inception was -67.82%, roughly equal to the maximum LLY drawdown of -68.24%. Use the drawdown chart below to compare losses from any high point for CV and LLY.
Loading graphics...
Drawdown Indicators
| CV | LLY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -67.82% | -68.24% | +0.42% |
Max Drawdown (1Y)Largest decline over 1 year | — | -30.26% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -34.48% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -34.48% | — |
Current DrawdownCurrent decline from peak | -49.45% | -17.00% | -32.45% |
Average DrawdownAverage peak-to-trough decline | -25.55% | -19.25% | -6.30% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 12.39% | — |
Volatility
CV vs. LLY - Volatility Comparison
Loading graphics...
Volatility by Period
| CV | LLY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 9.04% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 26.21% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 107.78% | 42.44% | +65.34% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 107.78% | 32.14% | +75.64% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 107.78% | 29.80% | +77.98% |
Financials
CV vs. LLY - Financials Comparison
This section allows you to compare key financial metrics between CapsoVision, Inc and Eli Lilly and Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities